>
//
>
Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.
Voluntary HIV Counseling and Testing of Hospital In-Patients to Protect Health Care Workers Is Not Cost-Effective, UCSF Study Finds
Business Wire (12/20/94)
A new cost-effectiveness study done by the University of California at San Francisco (UCSF) found that there is no justification for voluntary HIV testing of hospital in- patients to prevent HIV-infection of health care workers. The researchers found that screening in-patients to detect infection may be cost effective when a significant number of the patients are HIV-infected. There are, however, ethical and policy concerns that must be adequately addressed before any large-scale counseling and testing program can be supported. The study was prompted by recommendations from the Centers for Disease Control and Prevention in 1993 to consider using voluntary HIV testing and counseling programs for in- patients between the ages of 15 and 54 in certain acute care hospitals in the United States. The researchers determined that if all in-patients were offered HIV counseling and testing, only 3.6 health care worker HIV infections would be prevented each year. The annual program cost would be $2.7 billion, or $753 million per infection averted. "In our view, this is not sufficiently cost-effective to justify testing to protect health care workers from HIV infection," said lead author Peter Lurie, of the UCSF Center for AIDS Prevention Studies.
941221
AD942278
Copyright © 1994 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. and many more are available free online at --> .